The declaration provided for in Article L. 5138-1 is sent to the Agence nationale de sécurité du médicament et des produits de santé by a person authorised to bind the company to which the establishment belongs, by any means enabling receipt to be acknowledged. It includes the following information:
1° The name or corporate name and address of the company to which the establishment belongs and the address of the establishment which carries out the activity of manufacturing, importing or distributing excipients;
2° The name and position of the declarant;
3° The nature of the activity or activities subject to declaration carried out by the establishment.
For manufacturers mentioned in 1° of Article R. 5124-2 and 1° of Article R. 5142-1 who import excipients for their own use, the mention of this activity in the statement provided for in Article R. 5124-46 or Article R. 5142-42 is equivalent to an import declaration.
Any change in the information contained in the declaration gives rise to a new declaration, communicated immediately to the Agency by any means capable of acknowledging receipt.
The cessation of activity of the establishment must be notified immediately, in the same way.